Mr. Derry of Western General Hospital in Edinburgh, United Kingdom, has no relevant financial relationships to disclose.)
Dr. Scheffer of Austin Health received honorariums and travel/conference expenses from BioMarin and GlaxoSmithKline for speaking engagements and advisory board membership.)
This article includes discussion of autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE, autosomal dominant sleep-related hypermotor epilepsy, ADSHE, nocturnal frontal lobe epilepsy, and NFLE. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.
Since autosomal dominant sleep-related hypermotor epilepsy (ADSHE) (also known as autosomal dominant nocturnal frontal lobe epilepsy; ADNFLE) was described in 1994, this dramatic disorder of motor seizures in sleep has been widely recognized. With the discovery of a mutation in the nicotinic acetylcholine receptor alpha4 subunit gene in 1 family, ADSHE became the first human epilepsy in which a gene was identified. Mutations have been found in genes encoding the nicotinic acetylcholine receptor alpha4, beta2, and alpha2 subunits. A sodium-gated potassium channel gene, KCNT1, has also been identified in severe ADNFLE, associated with intellectual disability and psychiatric features. Missense mutations in both the promoter and coding regions of CRH, the gene encoding corticotropin-releasing hormone, have been identified in ADSHE families. Mutations in mTOR regulator genes, DEPDC5, NPRL2, and NPRL3, have been identified as causes of familial focal epilepsy with variable foci, of which a subgroup of families has ADSHE.
• Autosomal dominant sleep-related hypermotor epilepsy (ADSHE) is characterized by clusters of nocturnal motor seizures.
• More severe cases may have intellectual disability and psychiatric features.
• ADSHE follows autosomal dominant inheritance with incomplete (70%) penetrance.
• ADSHE is associated with mutations of acetylcholine nicotinic receptor genes CHRNA4, CHRNB2, and CHRNA2, the sodium-gated potassium channel gene KCNT1, corticotropin-releasing hormone gene (CRH), and the genes DEPDC5, NPRL2, and NPRL3 involved in mTOR regulation.
• Some ADSHE families may be regarded as a subset of familial focal epilepsy with variable foci due to mutations in the GATOR1 genes, DEPDC5, NPRL2, and NPRL3.
Historical note and terminology
In 1981, 5 patients with frequent sleep-related events were reported by Lugaresi and Cirignotta (Lugaresi and Cirignotta 1981). These individuals had frequent stereotyped events, occurring almost every night, characterized by tonic and dystonic posturing and coarse, violent movements. The episodes all arose from stage 2 sleep, were not associated with epileptiform abnormalities on EEG, and were responsive to carbamazepine. Lugaresi and Cirignotta named this condition hypnogenic paroxysmal dystonia and suggested 3 possible underlying mechanisms. They suggested that the movements could be a form of sleep terror (ie, a benign parasomnia), a form of paroxysmal dystonia triggered by arousal from sleep (ie, a movement disorder), or a form of epilepsy arising from deep or mesial structures.
Over the next decade, further reports of this condition appeared in the literature. Although evidence for an epileptic basis was seen in some cases, in others the association with the subsequent development of Huntington disease (Lugaresi et al 1986) or concurrent reflex dystonia (Lehkuniec et al 1988) suggested that nocturnal paroxysmal dystonia was in fact a movement disorder. It was hypothesized, therefore, that the condition was heterogeneous and included paroxysmal disorders with different underlying etiologies. In general, brief attacks (which tended to be more responsive to antiepileptic agents) were held to be epileptic in origin, whereas the rarer longer attacks (many of which did not respond to antiepileptic drugs) were thought to represent extrapyramidal disturbances (Tinuper 2002). The condition became widely known as nocturnal paroxysmal dystonia.
At this time, reports were also emerging of patients with multiple, very brief, arousals from NREM sleep. These arousals caused significant sleep fragmentation and daytime somnolence, and in some cases appeared to have an epileptic basis (Peled and Lavie 1986; Montagna et al 1990). In addition, the phenomenon of episodic nocturnal wanderings was described (Pedley and Guilleminault 1977; Maselli et al 1988), characterized by longer episodes of vocalization, complex and sometimes violent automatisms, and ambulation.
The nature of these episodes, particularly nocturnal paroxysmal dystonia, was widely debated (Lee et al 1985; Berger et al 1987), but as more work was performed on the semiology of frontal lobe epilepsy, the similarities between nocturnal paroxysmal dystonia and frontal lobe seizures became apparent. Both conditions presented with prominent tonic and dystonic features or bizarre automatisms, were often associated with preservation of consciousness, and frequently had no associated ictal EEG changes (Rasmussen 1983; Spencer et al 1983; Williamson et al 1985; Waterman et al 1987; Morris et al 1988). The tendency of frontal lobe seizures to occur in sleep was also recognized. These striking similarities, combined with the presence of definite epileptiform discharges in a number of nocturnal paroxysmal dystonia patients, resulted in the view of some that most (if not all) nocturnal paroxysmal dystonia cases were epileptic in origin (Tinuper et al 1990; Meierkord et al 1992), and the term “nocturnal frontal lobe epilepsy” (NFLE) was coined. In 2016, the results of a consensus conference were published, proposing the name be changed to “sleep-related hypermotor epilepsy” (SHE), emphasizing the importance of sleep triggering seizure onset rather than time of day and the evidence that seizures do not always arise in the frontal lobe (Tinuper et al 2016).
In 1994, Scheffer and colleagues reported a group of families from Australia, Canada, and the United Kingdom in whom SHE was inherited in an autosomal dominant fashion, thus, describing autosomal dominant sleep-related hypermotor epilepsy (ADSHE) (Scheffer et al 1994). The largest family in this study was mapped with linkage analysis to chromosome 20q (Phillips et al 1995), and a genetic mutation was subsequently identified in a nicotinic acetylcholine subunit gene (Steinlein et al 1995), making ADSHE the first form of human epilepsy for which the fundamental genetic basis had been established.
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.